NCT04401527View on ClinicalTrials.gov

Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 22, 2020

Primary Completion Date

August 15, 2020

Study Completion Date

August 15, 2020

Conditions
COVID-19Acute Respiratory Distress SyndromeAcute Respiratory Failure
Interventions
DRUG

Sodium Nitrite

Continuous intravenous infusion of Sodium Nitrite Injection

DRUG

Normal Saline

Continuous intravenous infusion of Normal Saline

Trial Locations (2)

33606

Participating Research Facility, Tampa

76104

Participating Research Facility, Fort Worth

Sponsors
All Listed Sponsors
lead

Hope Pharmaceuticals

INDUSTRY